Schulz, M., Biedermann, P., Bock, C., Hofmann, J., Choi, M., Tacke, F., . . . Mueller, T. (2020). Rituximab-Containing Treatment Regimens May Imply a Long-Term Risk for Difficult-To-Treat Chronic Hepatitis E. Int J Environ Res Public Health.
Citação norma ChicagoSchulz, Marten, Paula Biedermann, Claus-Thomas Bock, Jörg Hofmann, Mira Choi, Frank Tacke, Leif Gunnar Hanitsch, and Tobias Mueller. "Rituximab-Containing Treatment Regimens May Imply a Long-Term Risk for Difficult-To-Treat Chronic Hepatitis E." Int J Environ Res Public Health 2020.
Citação norma MLASchulz, Marten, et al. "Rituximab-Containing Treatment Regimens May Imply a Long-Term Risk for Difficult-To-Treat Chronic Hepatitis E." Int J Environ Res Public Health 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.